Shen, Ying-ChunYing-ChunShenLee, Pei-ChangPei-ChangLeeKuo, Yu-LunYu-LunKuoWEI-KAI WUChen, Chieh-ChangChieh-ChangChenLei, Chengh-HauChengh-HauLeiYeh, Ching-PingChing-PingYehCHIUN HSUCHIH-HUNG HSULin, Zhong-ZheZhong-ZheLinShao, Yu-YunYu-YunShaoLu, Li-ChunLi-ChunLuLiu, Tsung-HaoTsung-HaoLiuChen, Chien-HungChien-HungChenWu, Ming-ShiangMing-ShiangWuHuang, Yi-HsiangYi-HsiangHuangCheng, Ann-LiiAnn-LiiCheng2022-09-162022-09-162021-07-242253-5969https://scholars.lib.ntu.edu.tw/handle/123456789/620606Gut microbiome has been associated with the efficacy of immune checkpoint inhibitors (ICI) in patients with various types of cancers but not yet in hepatocellular carcinoma (HCC).enbiomarkers; gut microbiome; hepatocellular carcinoma; immune checkpoint inhibitor[SDGs]SDG3An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinomajournal article10.2147/JHC.S31569634336726WOS:000677482900001